Skip to main content

MoneyWorks4Me

Natco Pharma informs about board meeting

29 Oct 2018 Evaluate

Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018, to consider and approve approval of the Unaudited Financial Results for the quarter ended 30th September, 2018, and considreation of buy-back of equity shares of the Company and related matters.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..